Teladoc Health to Announce First Quarter 2025 Financial Results
Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) Apr. 16, 2025 11:48 AM ET [Seeking Alpha]
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction [Yahoo! Finance]
Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Bank of America Co. from $9.50 to $8.00. They now have a "neutral" rating on the stock.
Digital health startup Transcarent takes Accolade private in $621 million deal [CNBC]